[24] reported that PGC-1α and TFAM expression were reduced, which indicated disruption of mitochondrial biogenesis in nonalcoholic steatohepatitis (NASH) and early fibrosis in mouse liver. Here, PPARGC1A is linked to metabolic dysfunction-associated steatohepatitis.